Seminars in Oncology
Volume 33, Issue 2 , Pages 195-201, April 2006

Familial Chronic Lymphocytic Leukemia

  • Gabrielle S. Sellick

      Affiliations

    • Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK.
  • ,
  • Daniel Catovsky

      Affiliations

    • Section of Haemato-Oncology, Institute of Cancer Research, Sutton, Surrey, UK.
  • ,
  • Richard S. Houlston

      Affiliations

    • Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK.
    • Corresponding Author InformationAddress correspondence to Dr Richard Houlston, Institute of Cancer Research, 15 Cotswold Rd, Sutton, Surrey SM2 5NG, UK.

The role of inherited genetic factors in the etiology of chronic lymphocytic leukemia (CLL) and other B-cell lymphoproliferative disorders (LPDs) is now well established. Significant familial aggregation of CLL and B-cell LPDs has been demonstrated, but the mode of inheritance is unknown. Identifying genes that when mutated confer an increased risk of these diseases is of immediate clinical relevance in terms of primary and secondary interventions. Furthermore, their identification provides for a greater understanding of the mechanisms of B-cell tumorigenesis in general. Here we review the current status of knowledge relating to inherited susceptibility to CLL and the strategies that are being employed to identify disease-causing mutations.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the Leukemia Research and the Arbib Foundation.

PII: S0093-7754(06)00022-4

doi:10.1053/j.seminoncol.2006.01.013

Seminars in Oncology
Volume 33, Issue 2 , Pages 195-201, April 2006